Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for AMRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 1998. Start Trial.
Date Value
December 31, 2025 310.87M
December 31, 2024 118.42M
December 31, 2023 99.11M
December 31, 2022 35.23M
December 31, 2021 256.74M
December 31, 2020 347.12M
December 31, 2019 152.82M
December 31, 2018 218.78M
December 31, 2017 77.92M
December 31, 2016 180.13M
December 31, 2015 340.35M
December 31, 2014 414.86M
December 31, 2013 413.13M
December 31, 2012 298.92M
Date Value
December 31, 2011 346.41M
December 31, 2010 348.40M
December 31, 2009 90.37M
December 31, 2008 119.98M
December 31, 2007 143.50M
December 31, 2006 29.83M
December 31, 2005 56.08M
December 31, 2004
December 31, 2003 15.50M
December 31, 2002 10.22M
December 31, 2001 35.47M
December 31, 2000 19.23M
December 31, 1999 7.413M
December 31, 1998 1.304M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Liquidia Corp. 190.68M
Eli Lilly & Co. 7.268B
Viatris, Inc. 1.454B
Pfizer Inc. 13.60B
Harmony Biosciences Holdings, Inc. 775.34M